T 1835/16 of 16.01.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T183516.20170116
- Date of decision
- 16 January 2017
- Case number
- T 1835/16
- Online on
- 25 January 2017
- Petition for review of
- -
- Application number
- 08838001.9
- IPC class
- A61K 31/4184C07D 487/04A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1
- Applicant name
- AbbVie Bahamas Ltd.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 100(1)
- Keywords
- Admissibility of appeal - missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.